Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of RIMBP3 mRNA | CTD | PMID:30165855 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RIMBP3 mRNA | CTD | PMID:28628672 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RIMBP3 mRNA | CTD | PMID:28628672 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of RIMBP3 mRNA | CTD | PMID:22941251 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of RIMBP3 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of RIMBP3 protein | CTD | PMID:35688186 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RIMBP3 mRNA | CTD | PMID:28628672 | diallyl disulfide | multiple interactions | EXP | | 6480464 | diallyl disulfide inhibits the reaction [tobacco tar analog results in decreased expression of RIMBP3 mRNA] | CTD | PMID:36758788 | Diallyl sulfide | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [tobacco tar analog results in decreased expression of RIMBP3 mRNA] | CTD | PMID:36758788 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of RIMBP3 mRNA | CTD | PMID:29803840 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RIMBP3 mRNA | CTD | PMID:28628672 | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of RIMBP3 mRNA | CTD | PMID:35984750 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of RIMBP3 mRNA | CTD | PMID:35811015 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of RIMBP3 mRNA | CTD | PMID:36326898 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of RIMBP3 mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of RIMBP3 mRNA | CTD | PMID:34973136 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of RIMBP3 gene | CTD | PMID:29154799 | |